# SVR12 in Genotype 3 HCV (F0-F2) Treated With RDV + SOF

> **NCT07316842** · — · ACTIVE_NOT_RECRUITING · sponsor: **Center of target therapy** · enrollment: 30 (actual)

## Conditions studied

- Viral Hepatitis C

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07316842
- **Lead sponsor:** Center of target therapy
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-09-17
- **Primary completion:** 2026-02-02
- **Final completion:** 2026-02-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07316842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07316842, "SVR12 in Genotype 3 HCV (F0-F2) Treated With RDV + SOF". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07316842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*